Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

The restoration of platelet levels is merely one of the indicators of the recovery phase in dengue. The work entitled “Immature platelet fraction as a clinical predictor for enhanced platelet ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

SFJ Pharmaceuticals (SFJ) and (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to study ...